195 filings
Page 6 of 10
4
ida9 oj6hipmv
15 May 20
Vir Biotechnology / Jay Parrish ownership change
7:18pm
8-K
x8izpme5sln4u
12 May 20
Vir Biotechnology Provides Corporate Update and Reports First Quarter 2020 Financial Results
4:05pm
DEFA14A
ofzllfhnw2ii
8 May 20
Additional proxy soliciting materials
4:10pm
D
5cv7hal kria1o
8 May 20
$32.44M in equity, sold $32.44M, 1 investor
4:04pm
D
7dfnqujutv6qhsy1
8 May 20
$250M in equity, sold $250M, 1 investor
4:01pm
4/A
r47rp5wlkby2d51g
7 May 20
Vir Biotechnology / ROBERT J MORE ownership change
8:03pm
SC 13G/A
pi5b8v1fm9 j5
7 May 20
Vir Biotechnology / Alaska Permanent Fund ownership change
7:04am
4
ehx8ympb
5 May 20
Vir Biotechnology / ROBERT J MORE ownership change
5:55pm
SC 13G
w0xjn71hw
4 May 20
Vir Biotechnology / GLAXOSMITHKLINE ownership change
4:18pm
8-K
x5oh3l njdaw4o
30 Apr 20
Other Events
8:00am
4
fyw11xc fwg
20 Apr 20
Vir Biotechnology / Phillip Pang ownership change
8:20pm
4
10gwxnbkz
16 Apr 20
Vir Biotechnology / GEORGE A SCANGOS ownership change
5:33pm
8-K
vxab 9pcozc9kept
10 Apr 20
Samsung Biologics and Vir Biotechnology Enter into Agreement for Large Scale Manufacture ofSARS-COV-2 Antibodies for Potential COVID-19 Treatment
8:01am
8-K
szkw8dz 3wlp
7 Apr 20
Entry into a Material Definitive Agreement
5:25pm
DEFA14A
9u4rfryfbndp4
6 Apr 20
Additional proxy soliciting materials
4:53pm
DEF 14A
47w07xuaq 9p2
6 Apr 20
Definitive proxy
4:52pm
8-K
5agpdzagg o5w3e611
6 Apr 20
Entry into a Material Definitive Agreement
8:02am
S-8
9e5j4ce
26 Mar 20
Registration of securities for employees
4:47pm
10-K
0ggtzwh40 61brvc
26 Mar 20
Annual report
4:08pm